{"id":2458,"date":"2018-01-24T15:29:08","date_gmt":"2018-01-24T12:29:08","guid":{"rendered":"https:\/\/venusmed.gr\/?page_id=2458"},"modified":"2018-01-26T18:55:01","modified_gmt":"2018-01-26T15:55:01","slug":"anichnefsi-emvryikou-dna-sto-mitriko-aima","status":"publish","type":"page","link":"https:\/\/venusmed.gr\/en\/iatrika-themata-2\/maieftika\/anichnefsi-emvryikou-dna-sto-mitriko-aima\/","title":{"rendered":"Detection of Fetal DNA in maternal blood"},"content":{"rendered":"<div class=\"wpb-content-wrapper\"><p>[vc_row css_animation=&#8221;&#8221; row_type=&#8221;row&#8221; use_row_as_full_screen_section=&#8221;no&#8221; type=&#8221;full_width&#8221; angled_section=&#8221;no&#8221; text_align=&#8221;left&#8221; background_image_as_pattern=&#8221;without_pattern&#8221;][vc_column][vc_column_text]Non-invasive prenatal testing (NIPT) analyses cell-free DNA circulating in the pregnant mother\u2019s blood. It is a new option in prenatal screening for Down syndrome (trisomy 21) and other common fetal chromosomal conditions (trisomies 18 and 13). This test can be requested for singleton pregnancies including IVF self donor, unrelated egg donor and surrogate pregnancies.[\/vc_column_text][\/vc_column][\/vc_row][vc_row css_animation=&#8221;&#8221; row_type=&#8221;row&#8221; use_row_as_full_screen_section=&#8221;no&#8221; type=&#8221;full_width&#8221; angled_section=&#8221;no&#8221; text_align=&#8221;left&#8221; background_image_as_pattern=&#8221;without_pattern&#8221;][vc_column][vc_empty_space][vc_widget_sidebar sidebar_id=&#8221;Anixneusi Emvriikou&#8221;][\/vc_column][\/vc_row][vc_row css_animation=&#8221;&#8221; row_type=&#8221;row&#8221; use_row_as_full_screen_section=&#8221;no&#8221; type=&#8221;full_width&#8221; angled_section=&#8221;no&#8221; text_align=&#8221;left&#8221; background_image_as_pattern=&#8221;without_pattern&#8221;][vc_column][vc_empty_space][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>[vc_row css_animation=&#8221;&#8221; row_type=&#8221;row&#8221; use_row_as_full_screen_section=&#8221;no&#8221; type=&#8221;full_width&#8221; angled_section=&#8221;no&#8221; text_align=&#8221;left&#8221; background_image_as_pattern=&#8221;without_pattern&#8221;][vc_column][vc_column_text]Non-invasive prenatal testing (NIPT) analyses cell-free DNA circulating in the pregnant mother\u2019s blood. It is a new option in prenatal screening for Down syndrome (trisomy 21) and other common fetal chromosomal conditions (trisomies 18 and 13). This test&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":2441,"menu_order":204,"comment_status":"closed","ping_status":"closed","template":"custom-tpl.php","meta":[],"_links":{"self":[{"href":"https:\/\/venusmed.gr\/en\/wp-json\/wp\/v2\/pages\/2458"}],"collection":[{"href":"https:\/\/venusmed.gr\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/venusmed.gr\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/venusmed.gr\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/venusmed.gr\/en\/wp-json\/wp\/v2\/comments?post=2458"}],"version-history":[{"count":0,"href":"https:\/\/venusmed.gr\/en\/wp-json\/wp\/v2\/pages\/2458\/revisions"}],"up":[{"embeddable":true,"href":"https:\/\/venusmed.gr\/en\/wp-json\/wp\/v2\/pages\/2441"}],"wp:attachment":[{"href":"https:\/\/venusmed.gr\/en\/wp-json\/wp\/v2\/media?parent=2458"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}